{
  "docId": "019de071-368f-770d-b306-cadfb30d59b4",
  "docSlug": "a64b1d8ea419e9037d657543bdbf6776",
  "documentTitle": "Alkermes | Results Presentation Deck | 13 slides",
  "authorId": "alkermes",
  "authorName": "Alkermes",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-07-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 4,
  "pageCount": 13,
  "prevPage": 3,
  "nextPage": 5,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-368f-770d-b306-cadfb30d59b4/4",
  "deckHref": "/decks/019de071-368f-770d-b306-cadfb30d59b4",
  "deckJsonHref": "/decks/019de071-368f-770d-b306-cadfb30d59b4.json",
  "deckAnchorHref": "/decks/019de071-368f-770d-b306-cadfb30d59b4#slide-4",
  "components": [
    {
      "bbox": {
        "h": 0.03,
        "w": 0.7,
        "x": 0.05,
        "y": 0.895
      },
      "kind": "disclaimer",
      "text": "*Full prescribing information, including boxed warning, for LYBALVI may be found at www.lybalvi.com/lybalvi-prescribing-information.pdf",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ac3ae2f6-888b-4504-87d3-a687792ac059",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.7,
        "x": 0.05,
        "y": 0.23
      },
      "kind": "list",
      "text": "Commercial Execution: Drove solid VIVITROL and ARISTADA growth year-over-year and sequentially",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1db8f137-dad7-4e98-84a4-becef97d608d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.9,
        "x": 0.05,
        "y": 0.38
      },
      "kind": "list",
      "text": "LYBALVI: Received FDA approval for the treatment of adults with schizophrenia and adults with bipolar I disorder",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "93fe384d-06cf-4b0a-b3e5-df726c3112be",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.9,
        "x": 0.05,
        "y": 0.53
      },
      "kind": "list",
      "text": "Nemvaleukin Alfa: Entered into clinical trial collaboration with MSD; Initiated ARTISTRY-6 phase 2 study; Presented ARTISTRY-1 and ARTISTRY-2 data at ASCO",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a2ecb899-fff7-47e1-9922-440e67e22e8f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.75,
        "x": 0.05,
        "y": 0.12
      },
      "kind": "title",
      "text": "Q2 2021 Commercial and Operational Execution",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5e75ba2e-ce99-4736-a01c-51c80d1d7bed",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "4b8b9367-b988-499d-babb-aecaf6806d28",
      "evidence": "list/bullet: Nemvaleukin Alfa: Entered into clinical trial collaboration with MSD; Initiated ARTISTRY-6 phase 2 study; Presented ARTISTRY-1 and ARTISTRY-2 data at ASCO",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 4,
      "from": 1,
      "beatId": "0af3db55-054e-4d45-8f8c-10472be74044",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "What Is",
      "beatSlug": "sparkline-what-is-1",
      "evidence": "The presentation starts with an overview of the company's performance and agenda",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Setup",
      "parentBeatSlug": "setup"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}